Teva Pharmaceutical Industries reported $740M in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
ALKERMES ALKS:US USD -60641000 26.18M
Amarin AMRN:US USD 1.43M 39.05M
Amgen AMGN:US USD 2.23B 436M
AstraZeneca AZN:LN USD 2.26B 427M
Biogen BIIB:US USD 872.1M 68.8M
Bristol Myers Squibb BMY:US USD 2.32B 418M
Eli Lilly And LLY:US USD 2.11B 169.2M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Gilead Sciences GILD:US USD 2.27B 565M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Henry Schein HSIC:US USD 221M 2M
Horizon Pharma HZNP:US USD 188.16M 41.16M
Merk MRK:US USD 4.81B 725M
Novartis NOVN:VX USD 3.33B 8M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Patterson Companies PDCO:US USD 60.1M 25.25M
Perrigo Ordinary Shares PRGO:US USD 52.2M 49.6M
Pfizer PFE:US USD 5.81B 3.89B
Revance Therapeutics RVNC:US USD -77484000 19.64M
Takeda 4502:JP JPY 146.99B 42.55B
Teva Pharmaceutical Industries TEVA:US USD 740M 6M
Xeris Pharmaceuticals Inc XERS:US USD -18780000 136K
Zoetis ZTS:US USD 725M 12M